alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Schwartz
Levitsky Feldman llp
 CHARTERED
ACCOUNTANTS
 LICENSED
PUBLIC ACCOUNTANTS
 TORONTO· MONTREAL




CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
 The
undersigned, Schwartz Levitsky Feldman llp, hereby consent to the use of our
name and the use of our opinion dated January 19, 2010 on the consolidated
financial statements of Pacific Copper Corp. (the “Company”) included in its
Annual Report on Form 10-K being filed by the Company, for the fiscal year ended
October 31, 2009.
 
 
 “SCHWARTZ
      LEVITSKY FELDMAN LLP”Toronto,
      Ontario, Canada
                Chartered
      AccountantsFebruary
      10, 2010
                Licensed
      Public Accountants
 1167
      Caledonia Road
                Toronto,
      Ontario M6A 2X1
                Tel:  416
      785 5353
                Fax:  416
      785 5663
| Skip to contentSocial Security Online | Social Security Benefits |
|---------------------------------------|--------------------------|

| www.socialsecurity.gov | Home  FAQs  Contact Us  Search | **Search**  |
|------------------------|-----------------------------------------------------------------|------------------|

| Office of the Chief Actuary | Benefits for Spouses |
|-----------------------------|----------------------|
This section of the FEDERAL REGISTER

contains notices of meetings published under

the ‘‘Government in the Sunshine Act’’ (Pub.

L. 94-409) 5 U.S.C. 552b(e)(3).

Sunshine Act Meetings Federal Register

65092

Vol. 60, No. 242

Monday, December 18, 1995

BOARD OF GOVERNORS OF THE FEDERAL

RESERVE SYSTEM

TIME AND DATE: 10 a.m., Thursday,

December 21, 1995.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, C Street

entrance between 20th and 21st Streets,

NW., Washington, DC 20551.

STATUS: Open.

MATTERS TO BE CONSIDERED:

Summary Agenda: Because of their

routine nature, no discussion of the

following items is anticipated. These

matters will be voted on without

discussion unless a member of the

Board requests that an item be moved to

the discussion agenda.

1. Proposed amendments to Regulation K

(International Banking Operations)

concerning general consent authority

(proposed earlier for public comment; Docket

No. R–0896).

2. Publication for comment of proposed

amendments to Regulation K (International

Banking Operations) concerning interstate

banking operations of foreign banking

organizations.

3. Any items carried forward from a

previously announced meeting.

Discussion Agenda: PLEASE NOTE

THAT NO DISCUSSION ITEMS ARE

SCHEDULED FOR THIS MEETING.

Note: If an item is moved from the

Summary Agenda to the Discussion Agenda,

discussion of the item will be recorded.

Cassettes will then be available for listening

in the Board’s Freedom of Information Office,

and copies can be ordered for $5 per cassette

by calling (202) 452–3684 or by writing to:

Freedom of Information Office, Board of

Governors of the Federal Reserve System,

Washington, DC 20551.

CONTACT PERSON FOR MORE INFORMATION:

Mr. Joseph R. Coyne, Assistant to the

Board; (202) 452–3204.

Dated: December 14, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–30817 Filed 12–14–95; 3:09 pm]

BILLING CODE 6210–01–P

BOARD OF GOVERNORS OF THE FEDERAL

RESERVE SYSTEM

TIME AND DATE: Approximately 10:15

a.m., Thursday, December 21, 1995,

following a recess at the conclusion of

the open meeting.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, C Street

entrance between 20th and 2lst Streets,

NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments, reassignments, and

salary actions) involving individual Federal

Reserve System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Mr. Joseph R. Coyne, Assistant to the

Board; (202) 452–3204. You may call

(202) 452–3207, beginning at

approximately 5 p.m. two business days

before this meeting, for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting.

Dated: December 14, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–30818 Filed 12–14–95; 3:09 pm]

BILLING CODE 6210–01–P
## Single-Year Tables Consistent With 2024 OASDI Trustees Report

2024 OASDI Trustees Report

            The tables listed below provide estimates by            alternative economic and/or demographic assumptions.            For some of the tables, we also provide historical data.            The tables carry the same designation as in the published report.            Reference should be made to the report            to understand the context in which the estimates are presented.          

            To allow easier access for people who may want to work with the data, we            also supply the tables in Excel.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 325 Enrolled Bill (ENR)]

        S.325

                    One Hundred Seventeenth Congress

                                 of the

                        United States of America

                          AT THE FIRST SESSION

           Begun and held at the City of Washington on Sunday,
          the third day of January, two thousand and twenty one

                                 An Act

 
To amend the Alyce Spotted Bear and Walter Soboleff Commission on Native 
 Children Act to extend the deadline for a report by the Alyce Spotted 
 Bear and Walter Soboleff Commission on Native Children, and for other 
                                purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. ALYCE SPOTTED BEAR AND WALTER SOBOLEFF COMMISSION ON NATIVE 
CHILDREN REPORT.
    Section 3(f) of the Alyce Spotted Bear and Walter Soboleff 
Commission on Native Children Act (Public Law 114-244; 130 Stat. 987) 
is amended, in the matter preceding paragraph (1), by striking ``3 
years'' and inserting ``5 years''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
ttcm_ex101.htm

  EXHIBIT 10.01
  
  	 
	 Tim Dohse, CEO
 (928) 360-8794 timdohse@hotmail.com 



 
  
 November 19, 2020 
  
 Tautachrome Inc. 
 1846 E Innovation Park Drive 
 Oro Valley, AZ 85755 
  
 Dear Dr. Leonard,
  
 Re: Waiver of Annual Fees
  
 Reference is made to the written technology license granted by Arknet Inc., an Arizona corporation (“Arknet”), to Tautachrome Inc., a Delaware corporation (“Tautachrome”), on or about October 17, 2018 (such license, the “License”), which permits Tautachrome to develop Licensed Products (as that term is defined in the License).
  
 As you are aware, under the terms of the License, Tautachrome is obligated to pay Arknet certain fees each year under the License (the “Annual Fees”), which, to date, remain unpaid.
  
 Arknet recognizes the importance of Tautachrome’s technology development with respect to Licensed Products, and considers such work to be essential to the optimal, most efficient path towards their successful global rollout.  Arknet is willing to enable Tautachrome to focus all of its resources on such development.
  
 Arknet therefore makes the following offer to Tautachrome, which offer is open for acceptance until 5:00 p.m. MT on November 20, 2020:
  
  	 1.
	 Arknet will waive its right to collect the Annual Fees under the License until such date as Tautachrome’s aggregate gross revenue from Licensed Products exceeds $500 million (such date, the “Due Date”). This waiver will not affect Arknet’s entitlement to the Annual Fees, which will continue to accrue and be owing by Tautachrome under the License.

	  
	  

	 2.
	 As consideration for the above-described waiver, Tautachrome will pay Arknet interest on all unpaid and owing Annual Fees, at the rate of 1% per annum, compounded annually and calculated from the date on which such Annual Fees are due under the License.

	  
	  

	 3.
	 All unpaid and owing Annual Fees together with all accrued and unpaid interest thereon will be due and payable by Tautachrome on the Due Date.

	  
	  

	 4.
	 Unless expressly modified by this Letter, all terms of the License shall remain unchanged for the duration of its term.



 
   
 If Tautachrome agrees to the above, please sign one copy of this letter in the space provided below and return it to me at the above address. By countersigning this letter, Tautachrome hereby irrevocably and unconditionally agrees to the foregoing. 
  
 This letter may be executed in counterparts and may be delivered by scanned format through email transmission, and all such counterparts shall constitute one and the same instrument.
  
 No amendment, waiver or modification of this letter shall be effective without an instrument in writing executed by all parties hereto.
   
  	  
	 Sincerely,
	  

	  
	  
	  
	  

	  
	 ARKNET INC.
	  

	  
	  
	  
	  

	  
	 By:
	 /s/ Tim Dohse
	  

	  
	  
	 Tim Dohse, CEO
	  



 
  
 ACCEPTED AND AGREED
 TAUTACHROME INC.
   
 By: /s/ Jon N. Leonard                                 
 Jon N. Leonard, CEO
  
  	 Arknet, Inc.                                                                
	 1846 E Innovation Park Drive 
	 Oro Valley, Arizona 85755
# TOC

# II.D1

# II.D2

# II.D3

# II.D4

# II.D5

# II.D6

# II.D7 & VI.E2

# II.D8 & IV.B4

# IV.A1

# IV.B1

# IV.B2

# IV.B3

# V.C1

# V.C2

# V.C3

# V.C4

# V.C5

# V.C6

# VI.E1

# VI.E3

# VI.E4

# VI.G1

# image5.png

# image6.png

# image7.png

# image8.png

# image9.png

# image1.png

# image10.png

# image11.png

# image12.png

# image13.png

# image14.png

# image15.png

# image16.png

# image17.png

# image18.png

# image19.png

# image2.png

# image20.png

# image21.png

# image22.png

# image3.png

# image4.png

# image23.png

# image24.png

# image25.png

# image26.png

# image27.png

# image28.png

# image29.png

# image30.png

# image31.png

# image32.png

# image33.png

# image34.png

# image35.png

# image36.png

# image37.png

# image38.png

# image39.png

# image40.png

# image41.png

# image42.png

# image43.png

# image44.png
Exhibit 99.01
 IMMERSION CORPORATION
RESTRICTED STOCK AGREEMENT
 Notice of Grant of
Restricted Stock  Grant Notice   Agreement   Award   Plan   Plan
Prospectus 
 1. Definitions and Construction.
 Definitions .
 Construction .
 2. Administration.
  3. The Award.
 Sale of Shares.
 1




---



##### 



Shares
 Time and Place of Exercise Purchase Date
 Restrictions on Resale
 4. Company Reacquisition Right.
 Grant of Company Reacquisition Right. Reacquisition Event
    Company Reacquisition Right Unvested Shares
 Exercise of Reacquisition Right
 2




---



##### 



Acceptance of Restrictions
 Non-Transferability of Unvested Shares
 3




---



##### 



Assignment
 Dividends, Distributions and Adjustments .
 5. Restrictive Legends and Stop Transfer Orders.
 Legends
 Stop-Transfer Notices
 Refusal to Transfer
 6. No Rights as Employee, Director or Consultant.
 4




---



##### 



7. Section83(b)Election.
 Election
 8. Effect of Change in Control on Award.
 Acquiror
 5




---



##### 



9. Adjustments for Changes in Capital Structure; Restrictions.
  Restrictions on Grant of the Award and Issuance of Shares .
 Fractional Shares .
 10. Tax Withholding.
 In General.
 Assignment of Sale Proceeds; Payment of Tax Withholding by Check.
 6




---



##### 



Withholding in Shares.
 11. Miscellaneous Provisions.
 Termination or Amendment.
 Nontransferability of the Award.
 Further Instruments.
 Binding Effect.
 7




---



##### 



Delivery of Documents and Notices.
 Description of Electronic Delivery .
 Consent to Electronic Delivery.
 Integrated Agreement.
 8




---



##### 



Applicable Law.
 Counterparts.
  Immersion Corporation
 
 
 RECIPIENT:
 
 Please Print Name
 9




---



##### 



RECEIPT AND CONSENT
 Company
  
 Signature
 Please
Print Name




---



##### 



STOCK POWER AND ASSIGNMENT  SEPARATE FROM STOCK CERTIFICATE
 [ COMPLETE AT THE TIME OF PURCHASE ] Agreement    Company  [ COMPLETE AT THE TIME OF PURCHASE ]
 
 PARTICIPANT(Signature)(Please Print Name)
 Instructions to Participant :
II 

117TH CONGRESS 

1ST SESSION S. 3348 

To reauthorize the Freedom’s Way National Heritage Area, and for other 

purposes. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 8, 2021 

Mr. MARKEY (for himself and Ms. WARREN) introduced the following bill; 

which was read twice and referred to the Committee on Energy and Natural Resources 

A BILL 

To reauthorize the Freedom’s Way National Heritage Area, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Freedom’s Way Na5 tional Heritage Area Act of 2021’’. 

6 SEC. 2. REAUTHORIZATION OF FREEDOM’S WAY NATIONAL 

7 HERITAGE AREA. 

8 (a) REMOVAL OF TOTAL FUNDING LIMIT.—Section 

9 8006(i) of the Omnibus Public Land Management Act of 

10 2009 (54 U.S.C. 320101 note; Public Law 111–11; 123 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 3348 IS

1 Stat. 1260) is amended by striking paragraph (1) and in2 serting the following: 

3 ‘‘(1) IN GENERAL.—There is authorized to be 

4 appropriated to carry out this section not more than 

5 $1,000,000 for each fiscal year.’’. 

6 (b) REAUTHORIZATION.—Section 8006(j) of the Om7 nibus Public Land Management Act of 2009 (54 U.S.C. 

8 320101 note; Public Law 111–11; 123 Stat. 1260) is 

9 amended by striking ‘‘the date that is 15 years after the 

10 date of enactment of this Act’’ and inserting ‘‘September 

11 30, 2036’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
Dismiss and Opinion Filed August 28, 2024

In The

Court of Appeals

Fifth District of Texas at Dallas

No. 05-24-00805-CV

BOBBIE SUE HAYES, Appellant

V.

DAVID LEE WALTERS, Appellee

On Appeal from the 59th Judicial District Court

Grayson County, Texas

Trial Court Cause No. FA-23-0058

MEMORANDUM OPINION

Before Justices Molberg, Nowell, and Kennedy

Opinion by Justice Nowell

On July 29, 2024, after receiving a copy of the trial court’s order vacating the 

appealed order on motion for appointment of receiver, we informed the parties that 

it appeared the appeal had become moot and was subject to dismissal for want of 

jurisdiction unless, within ten days, appellant showed cause as to why the appeal 

should not be dismissed. See City of Dallas v. Woodfield, 305 S.W.3d 412, 416 

(Tex. App.—Dallas 2010, no pet.). To date, appellant has not responded. 
–2–

Accordingly, we dismiss the appeal. See TEX. R. APP. P. 42.3(a); Woodfield, 305 

S.W.3d at 416.

240805f.p05

/Erin A. Nowell//

ERIN A. NOWELL

JUSTICE
–3–

Court of Appeals

Fifth District of Texas at Dallas

JUDGMENT

BOBBIE SUE HAYES, Appellant

No. 05-24-00805-CV V.

DAVID LEE WALTERS, Appellee

On Appeal from the 59th Judicial 

District Court, Grayson County, 

Texas

Trial Court Cause No. FA-23-0058.

Opinion delivered by Justice Nowell, 

Justices Molberg and Kennedy 

participating.

In accordance with this Court’s opinion of this date, we DISMISS the appeal.

We ORDER that appellee David Lee Walters recover his costs, if any, of this 

appeal from appellant Bobbie Sue Hayes.

Judgment entered this 28th day of August, 2024.
Exhibit 32.1




CERTIFICATION PURSUANT TO


18 U.S.C. Section 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Advanced BioMedical Technologies Inc. (the “Company”) on Form 10-K for the period ended October 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Wang Hui, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1) The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and




(2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Dated this 14th day of February, 2012./s/ Wang HuiWang Hui, Director and Chief Executive Officer
Exhibit 32.1



CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S. C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



In connection with the annual report on Form 10-K/A of Aytu BioScience,
Inc. (the “Company”) for the fiscal year ended June 30, 2017, as filed with the Securities and Exchange Commission
on the date hereof (the “Report”), each of Joshua R. Disbrow, Chief Executive Officer (Principal Executive Officer),
and Gregory A. Gould, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his
knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|Dated: October 12, 2017                                                                | 
|-------------------------------------------------------------------------------------- | 
|                                                                                       | 
|/s/ Joshua R. Disbrow                                                                  | 
|Joshua R. Disbrow                                                                      | 
|Chief Executive Officer (Principal Executive Officer)                                  | 
|/s/ Gregory A. Gould                                                                   | 
|Gregory A. Gould                                                                       | 
|Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
#### John Staats, Respondent, v. Thomas Garrett, Appellant.

Judgment reversed, new trial granted; referee discharge costs to abide event.

Opinion by

Landon, J.
II 

117TH CONGRESS 

1ST SESSION S. 3380 

To prohibit the Administrator of the Environmental Protection Agency from 

retroactively reducing certain determinations under the Renewable Fuel 

Program, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 14, 2021 

Ms. KLOBUCHAR (for herself, Mr. GRASSLEY, Ms. DUCKWORTH, and Ms. 

ERNST) introduced the following bill; which was read twice and referred 

to the Committee on Environment and Public Works 

A BILL 

To prohibit the Administrator of the Environmental Protection Agency from retroactively reducing certain determinations under the Renewable Fuel Program, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Defend the Blend 

5 Act’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 3380 IS

1 SEC. 2. PROHIBITION AGAINST RETROACTIVE REDUCTIONS 

2 OF DETERMINATIONS UNDER THE RENEW3 ABLE FUEL PROGRAM. 

4 The Administrator of the Environmental Protection 

5 Agency may not reduce any applicable volume determined 

6 under paragraph (2) of section 211(o) of the Clean Air 

7 Act (42 U.S.C. 7545(o)), or any renewable fuel obligation 

8 or applicable percentage determined under paragraph (3) 

9 of that section, that has already been finalized for a cal10 endar year. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
<PAGE>
                                                                    EXHIBIT 21.1

                      FISHER SCIENTIFIC INTERNATIONAL INC.
                            WORLDWIDE SUBSIDIARY LIST

<TABLE>
<CAPTION>
                                                     PERCENTAGE   STATE/COUNTRY
                                                     OWNERSHIP    INCORPORATION
                                                     ----------   -------------
<S>                                                  <C>          <C>
Fisher Scientific Company L.L.C...................   100          Delaware
Fisher Scientific Company.........................   100          Canada
Fisher Hamilton L.L.C.............................   100          Delaware
Systems Manufacturing Corporation.................   100          Delaware
Alchematrix LLC...................................   100          Delaware
Fisher Scientific GmbH............................    93.4        Germany
Fisher Scientific of the Netherlands B.V..........   100          Netherlands
Fisher Scientific B.V.............................   100          Netherlands
Fisher Scientific Worldwide Inc...................   100          Delaware
Fisher Scientific Worldwide Holdings C.V..........   100          Netherlands
Fisher Scientific Europe Holdings B.V.............   100          Netherlands
Fisher Clinical Services Holdings Gmbh............   100          Switzerland
Fisher Clinical Services AG.......................   100          Switzerland
Fisher Scientific Belgium Holding B.V.B.A. .......   100          Belgium
Acros Organics B.V.B.A............................   100          Belgium
Fisher Scientific Holding Company.................   100          Delaware
Fisher Scientific Holding U.K., Limited...........   100          United Kingdom
Fisher Scientific U.K., Limited...................   100          United Kingdom
Fisher Scientific The Hague IB.V. ................   100          Netherlands
Fisher Bioblock Scientific S.A.S..................   100          France
Fisher Scientific S.A.S...........................   100          France
FSI Receivables Corp. ............................   100          Delaware
Medical Analysis Systems, Inc. ...................    71          California
Fisher Clinical Services Inc. ....................   100          Pennsylvania
Cole-Parmer Instrument Company....................   100          Illinois
</TABLE>
#### The People of the State of New York, Respondent, v. Miguel Chacon, Appellant.

— Judgment affirmed. Opinions by

Daniels, J., and Davis. P. J.,

and by Brady, J., disseuting.